Orally active antischistosomal early leads identified from the open access malaria box
about
Repurposing drugs for the treatment and control of helminth infectionsOpen Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and BeyondMechanically produced schistosomula as a higher-throughput tools for phenotypic pre-screening in drug sensitivity assays: current research and future trendsEvaluation of an FDA approved library against laboratory models of human intestinal nematode infectionsActivities of N,N'-Diarylurea MMV665852 analogs against Schistosoma mansoniActivity Profile of an FDA-Approved Compound Library against Schistosoma mansoniScreening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar EchinococcosisStructure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoniBiological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathwayRepurposing of the Open Access Malaria Box for Kinetoplastid Diseases Identifies Novel Active Scaffolds against Trypanosomatids.A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugsFreeze-fracture investigation of the red pulp of human spleen.Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni.Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways.QSAR-Driven Discovery of Novel Chemical Scaffolds Active against Schistosoma mansoni.Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery.Infectious disease. A return to the pre-antimicrobial era?The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases.Discovery of New Anti-Schistosomal Hits by Integration of QSAR-Based Virtual Screening and High Content Screening.Antischistosomal agents: state of art and perspectives.Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.Targeted Phenotypic Screening in Plasmodium falciparum and Toxoplasma gondii Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules.Using an open source model to accelerate schistosomiasis drug research.Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry.Progress in antischistosomal N,N'-diaryl urea SAR.The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery
P2860
Q26823355-C19E281D-925E-44AB-9C88-73BD8EF1198AQ27826351-5F4C1C83-7863-42A3-98BE-445AC5563690Q28071848-A8D22A13-A4A5-494C-A71E-407816D9F7F5Q28383181-02A19174-C842-4195-A2C1-A78A27448C9CQ28389729-3A7BFD53-8158-47E8-B007-96A64F9F5113Q28546955-1E5DDAD9-061A-46ED-AE63-72E03372F5EFQ28550703-545D2781-C10A-443D-9EAD-8BFC28302CCEQ28552326-2DD36054-3C9E-4910-83CE-357A604E3ACCQ28821118-0DF1D407-152B-4A79-8686-EC6107CEF931Q30487641-86E6552F-C620-4D9E-8222-51E04BCE8AC6Q34597517-A80A1F79-35FC-485A-8871-EF45D46B27CDQ35800023-082C7566-51F3-4749-9D2F-EB64E732FB20Q35944679-61985DAA-562F-4C6C-AA6A-5FB7E3755589Q37358648-4CE0D7F6-F49E-4301-9CDD-792728BDFFC0Q37616239-F3432058-6225-421E-9B95-29EAEE6EB030Q37726920-D646BCF7-C668-41FC-A622-888676FE62BFQ38695331-9783DA67-35A1-4BF6-A35F-93EA7CCF8DF6Q38889156-CFD97A34-FB63-4EFA-9D28-6E72C332F514Q38943630-D184ECF4-CB08-438B-AFE7-0FE8326A76AEQ39300204-3DFEC2CD-FF81-44FC-8494-C924C1C865A2Q47784982-258E32D1-C8BC-4236-A2A4-1FE2A8F3EA2BQ48016385-7649EB39-9D89-4B9D-A045-9BC4D6F5C228Q48022900-7F4F3571-BB66-446A-9BD9-10E2A8A8076DQ48327693-4005C622-E9F5-4F4B-A5B6-35C774CB720AQ50047043-CA1886C1-879D-4759-B6B5-54D7623C4E7EQ50114403-83CACED7-4073-48E1-941B-14D31156A726Q56514272-E5AED471-CA5C-46E8-96E1-CA75C75EFF9E
P2860
Orally active antischistosomal early leads identified from the open access malaria box
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Orally active antischistosomal early leads identified from the open access malaria box
@ast
Orally active antischistosomal early leads identified from the open access malaria box
@en
Orally active antischistosomal early leads identified from the open access malaria box
@nl
type
label
Orally active antischistosomal early leads identified from the open access malaria box
@ast
Orally active antischistosomal early leads identified from the open access malaria box
@en
Orally active antischistosomal early leads identified from the open access malaria box
@nl
prefLabel
Orally active antischistosomal early leads identified from the open access malaria box
@ast
Orally active antischistosomal early leads identified from the open access malaria box
@en
Orally active antischistosomal early leads identified from the open access malaria box
@nl
P2093
P2860
P50
P3181
P1476
Orally active antischistosomal early leads identified from the open access malaria box
@en
P2093
Katrin Ingram-Sieber
Noemi Cowan
Nuha R Mansour
Quentin D Bickle
Thomas Spangenberg
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0002610
P407
P577
2014-01-01T00:00:00Z